437
Views
34
CrossRef citations to date
0
Altmetric
Review

Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives

, ORCID Icon, & ORCID Icon
Pages 113-126 | Published online: 17 Oct 2019

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.00828736335
  • Uchino M, Uchino Y, Dogru M, et al. Dry eye disease and work productivity loss in visual display users: the Osaka study. Am J Ophthalmol. 2014;157:294–300. doi:10.1016/j.ajo.2013.10.01424184225
  • Qiao J, Yan X. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1797–1803. doi:10.2147/OPTH.S3318224043929
  • Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52:1922–1929. doi:10.1167/iovs.10-6997a21450913
  • Giannaccare G, Pellegrini M, Sebastiani S, et al. Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials. Cornea. 2019;38:565–573. doi:10.1097/ICO.000000000000188430702470
  • Lindsley K, Matsumara S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD005556.pub2
  • Thode AR, Latkany RA. Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD). Drugs. 2015;75(11):1177–1185. doi:10.1007/s40265-015-0432-826130187
  • Villani E, Garoli E, Canton V, Pichi F, Nucci P, Ratiglia R. Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol. 2015;35:319–323. doi:10.1007/s10792-014-9947-324752646
  • Doan S, Chiambaretta F, Baudouin C; ESPOIR study group. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study. J Fr Ophtalmol. 2014;37:763–772. doi:10.1016/j.jfo.2014.06.00425282620
  • Purslow C. Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction. Contact Lens Anterior Eye. 2013;36:226–231. doi:10.1016/j.clae.2013.02.00923566749
  • Greiner JV. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012;37:272–278. doi:10.3109/02713683.2011.63172122324772
  • Friedland BR, Fleming CP, Blackie CA, Korb DR. A novel thermodynamic treatment for meibomian gland dysfunction. Curr Eye Res. 2011;36:79–87. doi:10.3109/02713683.2010.50952921281063
  • Korb DR, Blackie CA. Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report. Cornea. 2010;29:930–933. doi:10.1097/ICO.0b013e3181ca36d620531168
  • Goto E, Monden Y, Takano Y, et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol. 2002;86:1403–1407. doi:10.1136/bjo.86.12.140312446375
  • Lienert JP, Tarko L, Uchino M, Christen WG, Schaumberg DA. Long-term natural history of dry eye disease from the patient’s perspective. Ophthalmology. 2016;123:425–433. doi:10.1016/j.ophtha.2015.10.01126610720
  • Zeev MSB, Miller DD, Latkany R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 2014;8:581–590.24672224
  • Alves M, Fonseca EC, Alves MF, et al. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf. 2013;11:181–192. doi:10.1016/j.jtos.2013.02.00223838019
  • Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med. 2003;32:78–87. doi:10.1002/lsm.1014512561039
  • Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol. 2008;159:628–632. doi:10.1111/j.1365-2133.2008.08702.x18565174
  • Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year Retrospective Study. Photomed Laser Surg. 2015;33:41–46. doi:10.1089/pho.2014.381925594770
  • Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17:104–110. doi:10.1016/j.jtos.2018.11.00430445177
  • Arita R, Mizoguchi T, Fukuoka S, Morishige N. Multicenter study of intense pulsed light therapy for patients with refractory meibomian gland dysfunction. Cornea. 2018;37:1566–1571. doi:10.1097/ICO.000000000000168730004962
  • Choi M, Han SJ, Ji YW, et al. Meibum Expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear infammatory cytokines. Sci Rep. 2019;9:1–8. doi:10.1038/s41598-018-37186-230626917
  • Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817–882. doi:10.2147/OPTH.S13070628496300
  • Li D, Lin S, Cheng B. Intense pulsed light treatment for meibomian gland dysfunction in skin types III/IV. Photobiomodul Photomed Laser Surg. 2019;37:70–76. doi:10.1089/photob.2018.450931050931
  • Seo KY, Kang SM, Ha DY, Chin HS, Jung JW. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Cont Lens Anterior Eye. 2018;41:430–435. doi:10.1016/j.clae.2018.06.00229958778
  • Yin Y, Liu N, Gong L, Song N. Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) Patients. Curr Eye Res. 2017;00:1–6.
  • Craig JP, Chen YH, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56:1965–1970. doi:10.1167/iovs.14-1576425678687
  • Jiang X, Lv H, Song H, et al. Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J Ophthalmol. 2016;1910694.27413540
  • Albietz JM, Schmid KL. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction. Clin Exp Optom. 2018;101:23–33. doi:10.1111/cxo.1254128585267
  • Guilloto Caballero S, García Madrona JL, Colmenero Reina E. Effect of pulsed laser light in patients with dry eye syndrome. Arch Soc Esp Oftalmol. 2017;92:509–515. doi:10.1016/j.oftal.2016.12.01828256362
  • Mudgil P. Antimicrobial role of human meibomian lipids at the ocular surface. Invest Ophthalmol Vis Sci. 2014;55:7272–7277. doi:10.1167/iovs.14-1551225316725
  • Nelson JD, Shimazaki J, Benitez-Del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930–1937. doi:10.1167/iovs.10-6997b21450914
  • Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100:300–306. doi:10.1136/bjophthalmol-2015-30741526781133
  • Wordinger RJ1. Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999;18:629–667.10438153
  • James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23:403–420. doi:10.1089/jop.2006.006717900234
  • Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol. 2015;26:314–318. doi:10.1097/ICU.000000000000016626058031
  • Muhlbauer W, Nath G, Kreitmair A. Treatment of capillary hemangiomas and nevi flammei with light. Langenbecks Arch Chir. 1976;(suppl):91–94.
  • Li D, Lin S, Cheng B. Intense pulsed light: from the past to the future. Photomed Laser Surg. 2016;34:435–447. doi:10.1089/pho.2016.413927697004
  • Wat H, Wu DC, Rao J, Goldman MP. Application of intense pulsed light in the treatment of dermatologic disease: a systematic review. Dermatol Surg. 2014;40:359–377. doi:10.1111/dsu.1242424495252
  • Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophtalmol. 2017;11:1167–1173. doi:10.2147/OPTH.S139894
  • Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. Biomed Res Int. 2014;2014:618206. doi:10.1155/2014/61820625276803
  • Bäumler W, Vural E, Landthaler M, Muzzi F, Shafirstein G. The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling. Lasers Surg Med. 2007;39:132–139. doi:10.1002/lsm.2040817066482
  • Nagymihályi A, Dikstein S, Tiffany J. The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res. 2004;78:367–370. doi:10.1016/s0014-4835(03)00197-015106914
  • Borchman D, Foulks G, Yappert M, et al. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:3805–3817. doi:10.1167/iovs.10-651421398284
  • Finis D, Hayajneh J, König C, Schrader S, Geerling G. Evaluation of an automated thermodynamic treatment (LipiFlow) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12:146–154. doi:10.1016/j.jtos.2013.12.00124725326
  • Arita R, Morishige N, Shirakawa R, Sato Y, Amano S. Effects of eyelid warming devices on tear film parameters in normal subjects and patients with meibomian gland dysfunction. Ocul Surf. 2015;13:321–330. doi:10.1016/j.jtos.2015.04.00526031204
  • Borchman D. The optimum temperature for the heat therapy for meibomian gland dysfunction. Ocul Surf. 2019;17:360–364. doi:10.1016/j.jtos.2019.02.00530794947
  • Geerling G, Tauber J, Baudouin C, et al. The International Workshop on Meibomian Gland Dysfunction: report of the Subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050–2064. doi:10.1167/iovs.10-6997g21450919
  • Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B. 1999;49:1–17. doi:10.1016/S1011-1344(98)00219-X10365442
  • Farivar S, Malekshahabi T, Shiari R. Biological effects of low-level laser therapy. J Lasers Med Sci. 2014;5:58–62.25653800
  • Takezaki S, Omi T. Sato, S Kawana S. Ultrastructural observations of human skin following irradiation with visible red light-emitting diodes (LEDs): a preliminary in vivo report. Laser Ther. 2005;14:153–160. doi:10.5978/islsm.14.153
  • Barolet D, Roberge C, Auger F, Boucher A, Germain L. Regulation of skin collagen metabolism in vitro using a pulsed 660 nm LED light source: clinical correlation with a single-blinded study. J Invest Dermatol. 2009;129:2751–2759. doi:10.1038/jid.2009.18619587693
  • Cuerda-Galindo E, Díaz-Gil G, Palomar-Gallego M, Linares-García-Valdecasas R. Increased fibroblast proliferation and activity after applying intense pulsed light 800–1200 nm. Ann Anat. 2015;198:66–72. doi:10.1016/j.aanat.2014.11.00525547460
  • Goldberg D. Current trends in intense pulsed light. J Clin Aesthet Dermatol. 2012;5:45–53.22768357
  • Liu J, Sheha H, Tseng S. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010;10:505–510. doi:10.1097/ACI.0b013e32833df9f420689407
  • Szkaradkiewicz A, Chudzicka-Strugała I, Karpiński T, et al. Bacillus oleronius and Demodex mite infestation in patients with chronic blepharitis. Clin Microbiol Infect. 2012;18:1020–1025. doi:10.1111/j.1469-0691.2011.03704.x22114987
  • Li J, O’Reilly N, Sheha H, et al. Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with facial rosacea. Ophthalmology. 2010;117:870–877. doi:10.1016/j.ophtha.2009.09.05720079929
  • Margalit A, Kowalczyk M, Żaba R, Kavanagh K. The role of altered cutaneous immune responses in the induction and persistence of rosacea. J Dermatol Sci. 2016;82:3–8. doi:10.1016/j.jdermsci.2015.12.00626747056
  • Lacey N, Delaney S, Kavanagh K, Powell F. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157(3):474–481. doi:10.1111/j.1365-2133.2007.08028.x17596156
  • Prieto V, Sadick N, Lloreta J, Nicholson J, Shea C. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med. 2002;30:82–85. doi:10.1002/lsm.1004211870785
  • Kirn T. Intense pulsed light eradicates Demodex mites. Skin Allergy News. 2002;33:37.
  • Enríquez-de-Salamanca A, Castellanos E, Stern M, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.20508732
  • Stevenson W, Chauhan S, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130:90–100. doi:10.1001/archophthalmol.2011.36422232476
  • Byun J, Choi H, Myung K, Choi YW. Expression of IL-10, TGF-β1 and TNF-α in cultured keratinocytes (HaCaT Cells) after IPL treatment or ALA-IPL photodynamic treatment. Ann Dermatol. 2009;21:12–17. doi:10.5021/ad.2009.21.1.1220548849
  • Huang J, Luo X, Lu J, et al. IPL irradiation rejuvenates skin collagen via the bidirectional regulation of MMP-1 and TGF-β1 mediated by MAPKs in fibroblasts. Lasers Med Sci. 2011;26:381–387. doi:10.1007/s10103-010-0870-121161310
  • Taylor M, Porter R, Gonzalez M. Intense pulsed light may improve inflammatory acne through TNF-α down-regulation. J Cosmet Laser Ther. 2014;16:96–103. doi:10.3109/14764172.2013.86419824245979
  • Wong WR, Shyu WL, Tsai JW, Hsu KH, Lee HY, Pang JH. Intense pulsed light modulates the expressions of MMP-2, MMP-14 and TIMP-2 in skin dermal fibroblasts cultured within contracted collagen lattices. J Dermatol Sci. 2008;51:70–73. doi:10.1016/j.jdermsci.2008.02.01118424078
  • Liu R, Rong B, Tu P, et al. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81–90. doi:10.1016/j.ajo.2017.08.02128887117
  • Jones D. Reactive oxygen species and rosacea. Cutis. 2009;74:17–20, 32–34.
  • Huang YY, Chen AH, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response. 2009;7:358–383. doi:10.2203/dose-response.09-027.Hamblin20011653
  • Augustin A, Spitznas M, Kaviani N, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol. 1995;233:694–698. doi:10.1007/bf001646718566825
  • Mejía LF, Gil JC, Jaramillo M. Intense pulsed light therapy: a promising complementary treatment for dry eye disease. Arch Soc Esp Oftalmol. 2019;94:331–336. doi:10.1016/j.oftal.2019.03.00931079987
  • Babilas P, Schreml S, Szeimies R, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42:93–104. doi:10.1002/lsm.2087720166155
  • Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–871. doi:10.1001/archderm.124.6.8693377516
  • Rong B, Tang Y, Tu P, et al. Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction. Photomed Laser Surg. 2018;36:326–332. doi:10.1089/pho.2017.440229688838
  • Rong B, Tang Y, Liu R, et al. Long-term effects of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction. Photomed Laser Surg. 2018;36:562–567. doi:10.1089/pho.2018.449930251914
  • Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51:249–253. doi:10.1016/j.jcjo.2016.01.00527521662
  • Vigo L, Giannaccare G, Sebastiani S, Pellegrini M, Carones F. Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction. J Vis Exp. 2019;146:1–7.
  • Crabb M, Chan WO, Taranath D, Huilgol SC. Intense pulsed light therapy (IPL) induced iritis following treatment for a medial canthal capillary malformation. Australas J Dermatol. 2014;55:289–291. doi:10.1111/ajd.1213724417640
  • Lee WW, Murdock J, Albini TA, O’Brien TP, Levine ML. Ocular damage secondary to intense pulse light therapy to the face. Ophthal Plast Reconstr Surg. 2011;27:263–265. doi:10.1097/IOP.0b013e31820c6e23
  • Pang AL, Wells K. Bilateral anterior uveitis after intense pulsed light therapy for pigmented eyelid lesions. Dermatol Surg. 2008;34:1276–1279. doi:10.1111/j.1524-4725.2008.34274.x18554285
  • Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg. 2005;31:1179–1187. doi:10.1111/j.1524-4725.2005.3192416176769
  • Javey G, Schwartz SG, Albini TA. Ocular complication of intense pulsed light therapy: iris photoablation. Dermatol Surg. 2010;36:1466–1468. doi:10.1111/j.1524-4725.2010.01661.x20636387
  • Karaca EE, Kemer OE, Özek D. Intense regulated pulse light for the meibomian gland dysfunction. Eur J Ophthalmol. 2018;1–4.29774756
  • Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea. 2016;35:318–322. doi:10.1097/ICO.000000000000073526785301
  • Ahmed SA, Taher IME, Ghoneim DF, Sawfat AEM. Effect of intense pulsed light therapy on tear proteins and lipids in meibomian gland dysfunction. J Ophthalmic Vis Res. 2019;14:3–10. doi:10.4103/jovr.jovr_12_1830820280
  • Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31:472–478. doi:10.1097/ICO.0b013e318225415a22378109
  • Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52:1994–2005. doi:10.1167/iovs.10-6997e21450917